AccuVein Secures $22.5M in Series B Financing

AccuVein Inc., a Huntington, NY-based creator of a and-held, non-contact vein illumination device, has secured $22.5m in Series B financing.

The round was led by MVM Life Science Partners and Bessemer Venture Partners, with participation from existing investors.

The company intends to use the funds to continue its expansion into new markets and enhance its focus on global customers.
In conjunction with the funding, Eric Bednarski of MVM Life Science Partners and Christopher Gabrieli of Bessemer Venture Partners have joined AccuVein’s board.

Led by CEO Ron Goldman, AccuVein has developed AV300, vein illumination solution that allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation. It is in use at more than 750 U.S. hospitals and available for sale in 63 countries.



Join the discussion